Sigbert Schiefer

Title: Sigbert Schiefer: Innovator in Lipoprotein Determination

Introduction

Sigbert Schiefer, an accomplished inventor based in Pahl, Germany, has made significant contributions to medical diagnostics through his innovative work in the determination of low-density lipoproteins (LDL). With a total of three patents to his name, Schiefer's inventions have the potential to improve health outcomes by facilitating better diagnostics.

Latest Patents

Schiefer's latest patents focus on a novel process and reagent for the determination of low-density lipoproteins in body fluids. The invention outlines a method where high-density lipoprotein (HDL) antibodies are added to a sample, allowing for the separation of insoluble components. This technique enables the determination of LDL or its components in the supernatant, providing a precise and efficient means of assessing cholesterol levels. The reagent developed for this process contains HDL antibodies, further enhancing its effectiveness in clinical settings.

Career Highlights

Sigbert Schiefer has been associated with Boehringer Mannheim GmbH, where he has played a key role in advancing research and development in the field of biochemical diagnostics. His dedication to innovation has led to impactful discoveries that continue to influence the medical industry.

Collaborations

Throughout his career, Schiefer has collaborated with esteemed colleagues, including Joachim Ziegenhorn and Brigitte Drager. These partnerships have fostered a collaborative environment that spurs further innovations and accelerates the development of novel diagnostic methods.

Conclusion

Sigbert Schiefer's contributions to the field of medical diagnostics, particularly in the determination of low-density lipoproteins, underscore the importance of innovation in healthcare. His patents not only represent significant technological advancements but also reflect his commitment to improving diagnostic processes, ultimately benefiting patients and the medical community alike.